SK
Samarendra Kumar Basu
About Samarendra Kumar Basu
Data last updated:
Samarendra Kumar Basu is an Additional Director at Larmark Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Larmark Pharmaceutical Private Limited reported revenue of ₹1.05 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Larmark Pharmaceutical Private Limited U74900WB2010PTC149728 | Additional Director | 02 Nov 2023 | 2010 | ₹1.05 Cr (FY 2025) | Active |
Board colleagues of Samarendra Kumar Basu
| Name | DIN | Company | Designation |
|---|---|---|---|
| Biswa Nath Pal | 07719523 | Larmark Pharmaceutical Private Limited | Director |
| Chaitali Basu | 09685434 | Larmark Pharmaceutical Private Limited | Director |
| Maitree Basu | 10442265 | Larmark Pharmaceutical Private Limited | Additional Director |
| Moinak Basu | 07488869 | Larmark Pharmaceutical Private Limited | Director |
| Parna Saha Basu | 10442245 | Larmark Pharmaceutical Private Limited | Additional Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Samarendra Kumar Basu
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Samarendra Kumar Basu
Samarendra Kumar Basu currently holds 1 directorship: Larmark Pharmaceutical Private Limited (Additional Director, since 02 Nov 2023, revenue ₹1.05 Cr (FY 2025)).
Samarendra Kumar Basu was first appointed on 02 Nov 2023 as Additional Director at Larmark Pharmaceutical Private Limited.
The current boards of Samarendra Kumar Basu's companies include Biswa Nath Pal (Larmark Pharmaceutical Private Limited), Chaitali Basu (Larmark Pharmaceutical Private Limited), Maitree Basu (Larmark Pharmaceutical Private Limited), Moinak Basu (Larmark Pharmaceutical Private Limited), Parna Saha Basu (Larmark Pharmaceutical Private Limited).